PreOmics

About:

PreOmics is a company that develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry.

Website: https://preomics.com/

Twitter/X: preomics

Top Investors: HTGF | High-Tech Gruenderfonds, Bruker, EASME - EU Executive Agency for SMEs, Think.Health, TBA Tyrolean Business Angel

Description:

PreOmics develops and provides innovative tools for customers around the world for mass spectrometry (MS)-based proteomics using cutting-edge technologies to support researchers in their protein analysis needs. PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. They at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Their mission is to provide you with the best possible solutions and at the highest quality to achieve your results faster, easier and in a more robust manner than ever before.